Skip to content

LABORATOIRES BAILLEUL

Active Private limited companyfounded 2002active for 23 yearsLennikse Baan 451, 1070 AnderlechtKBO/BCE: BE 0479.194.945 subsidiary of Laboratoires Bailleul International S. Etr.

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak €6.7m (2025)
€6.7m▲ 6.6%
peak €450,806 (2008)
€114,980▼ 23.9%
peak €2.1m (2011)
€1.9m▲ 6.6%
€587,049▲ 9.7%
peak 12.8 FTE (2025)
12.8 FTE▲ 10.3%
Board4 names since 2019
Owners5 names in the annual accounts
Documentsfilings and deeds
05-06-202656 days before the deadline
2025financial year
Staff from 11.6 FTE to 12.8 FTEInvestments €24,530Cash from €40,349 to €137,510

Key points

from the 2025 annual accounts

Equity

€1.9m ▲ 6.6%

LABORATOIRES BAILLEUL has made a profit in every financial year since 2006.

Investments

€24,530 4.5 × depreciation
2021202220242025

Green is investment, beige is depreciation. Machinery stands 231.6% higher than in 2024.

Checked score

93
Excellent
Financially stronger than 41% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: < 0.1%▼ -0.1 percentage points vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

100=equity 76.0% of total assets
48+4short-term debt 23.8% · cash 5.6%
61-2return on assets 4.7%

Score breakdown

lowers risk
Sector: Human health activities (NACE 86)
Equity €1.9m (76.0% of total assets)
Figures for financial year 2025 (filed on 05-06-2026)
Profit of €114,980 (financial year 2025)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 16% on liquidity, 15% on profitability and 57% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 14,766 companies had the same profile as LABORATOIRES BAILLEUL has now. Each dot stands for 37 companies, two years later.

96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of LABORATOIRES BAILLEUL itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,766 companies, not a prediction for LABORATOIRES BAILLEUL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €170,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 4.13 (4.26 in 2024), above the usual 1.5. Short-term debt is 23.8% and cash 5.6% of total assets. 24% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €1.9m (76.0% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 05-06-2026)
NBB · annual accounts
lowers risk · Profit of €114,980 (financial year 2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
56 days early
2024
49 days early
2023
48 days early
2022
33 days early
2021
40 days early
2020
30 days early
2019
36 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 42 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

LB
Director, since 19-06-2019
CV
Auditor, Erik SNAUWAERT
Board & ownership

Recent changes

Appointment: Callens Vandelanotte SA (statutory auditor) General meeting of 04-06-2026 · Gazette deed
Permanent representatives: Francesco Cavone and Laurent Coupé Board meeting of 22-03-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0479194945
Appointment: Callens Vandelanotte SA (statutory auditor) Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
LABORATOIRES BAILLEUL Anderlecht €6.7m 3.1% 76.0% 12.8
EasyNurse.be Grobbendonk €3.1m -17.7% 7.8% 17.9
PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE Woluwe-Saint-Lambert €3.4m 2.8% 50.4% 8
Experconsult Brussels €2.5m 9.3% 81.7% 5.2
RELIANCE - L'ASSOCIATION REGIONALE DES SOINS PALLIATIFS DE MONS-BORINAGE - LA LOUVIERE - SOIGNIES La Louvière €1.6m 18.0% 75.1% 16.4
Wijkgezondheidscentrum De Central Leuven €1.5m 13.8% 67.5% 16.9
Centrum voor Ambulante Revalidatie D.A.T. Tienen €2.0m 2.0% 76.2% 24.5
-10%0%10%20%€2m€20m€200mLABORATOIRES BAILLEULEBIT margin

Grey: the largest companies of the sector (human health (NACE 86)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as LABORATOIRES BAILLEUL: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €1.7m and €3.7m, founded between 1994 and 2005.

Official details

Source: KBO
Status
Active since 31-12-2002Normal situation
Registered office
90 active companies are registered at this addressSource: KBO register, as of 8 November 2026.
Activity
Nutrition and dietetics servicesNACE 86995and 1 other
Establishment unit
2.126.993.6301140 Evere, since 23-04-2003
Financial year end
31 December
Peppol
Reachable since 23-09-2025
Company details

Annual accounts 2025

€2.4m▲ 7.3%
Employeeson 31-12-2025
13▲ 18.2%
Filing
Filed on 05-06-2026, 56 days before the end of the filing period
Financials

Insights on LABORATOIRES BAILLEUL

LABORATOIRES BAILLEUL has existed since 2002. Turnover grew from €3.1m in 2014 to €6.7m in 2025 and staff from 8 to 12.8 full-time equivalents.

Turnover has grown every year since 2022.

Laboratoires Bailleul International S. Etr. holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LABORATOIRES BAILLEUL

What is the company number of LABORATOIRES BAILLEUL?
The company number of LABORATOIRES BAILLEUL is 0479.194.945. The VAT number is the same number with BE in front: BE 0479.194.945.
Where is LABORATOIRES BAILLEUL based?
The registered office is at Lennikse Baan 451, 1070 Anderlecht.Company details
What does LABORATOIRES BAILLEUL do?
According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
What is the legal form of LABORATOIRES BAILLEUL?
LABORATOIRES BAILLEUL is a private limited company (BV).
When was LABORATOIRES BAILLEUL founded?
LABORATOIRES BAILLEUL was founded on 31-12-2002.
Is LABORATOIRES BAILLEUL still active?
Yes, LABORATOIRES BAILLEUL is an active enterprise in the KBO register.
How many employees does LABORATOIRES BAILLEUL have?
LABORATOIRES BAILLEUL had an average of 12.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of LABORATOIRES BAILLEUL?
The turnover of LABORATOIRES BAILLEUL was €6.7m in financial year 2025, according to the filed annual accounts.
Is LABORATOIRES BAILLEUL profitable?
In financial year 2025, LABORATOIRES BAILLEUL made a profit of €114,980.
Where can I find the annual accounts of LABORATOIRES BAILLEUL?
LABORATOIRES BAILLEUL filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LABORATOIRES BAILLEUL due?
LABORATOIRES BAILLEUL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.